Thu, May 23, 2024
Wed, May 22, 2024
Tue, May 21, 2024
Mon, May 20, 2024
Fri, May 17, 2024
Thu, May 16, 2024

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Decreased Target to $43 on, May 20th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-43-on-may-20th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Decreased Target from $47 to $43 on, May 20th, 2024.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 6 other peers that have a rating on BBIO. Out of the 6 peers that are also analyzing BBIO, 1 agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Kostas Biliouris of "BMO Capital" Initiated at Hold and Held Target at $37 on, Wednesday, January 31st, 2024


These are the ratings of the 5 analyists that currently disagree with Raghuram


  • Cory Kasimov of "Evercore ISI Group" Initiated at Buy and Held Target at $50 on, Tuesday, May 14th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $45 on, Wednesday, March 20th, 2024
  • Josh Schimmer of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $70 on, Tuesday, March 19th, 2024
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Decreased Target to $53 on, Tuesday, March 5th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $46 on, Friday, February 23rd, 2024

Publication Contributing Sources